Scrip
Clinica
Scrip Regulatory Affairs
Scrip Clinical Research
AnimalPharm
Email ID
Password
Forgotten your password?
Sign me in automatically next time
Advanced Search
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Cancer
|
Cardiovascular
|
Infection
|
Metabolic
|
Musculoskeletal
|
CNS
|
Respiratory
|
Gastrointestinal
|
Other
|
Therapy Sector Stage - Cardiovascular
About Us
Getting Started
Subscribe
Free Trial
Advertise
Awards
White Papers
Executive Briefing
Classifieds
Recruitment
JOB OF THE WEEK
Promote your vacancy here
SCRIP's ONLINE DIRECTORY
Classified ads
LATEST NEWS
Comparative efficacy should have a "formal role in drug licensing"
08 September 2011
NICE to review Fabre's Javlor again as comparison with unlic...
Big pharma abandoning HIV discounts in middle-income countri...
Genzyme and ISIS submit first filing for mipomersenin EU to treat FH
28 July 2011
Bayer/J&J report positive Xarelto results in Japanese AF patients
26 July 2011
Familial cholesterol tests from Gen-Probe, Progenika fall short of NICE expectations
26 July 2011
AstraZeneca heartened by US FDA nod to antiplatelet medicine Brilinta
21 July 2011
>> More News...
LATEST ANALYSIS
Challenges and opportunities in the Philippine pharma market
08 January 2010
2010 Scrip 100 - Japan price cuts to sting at home and abroad
09 December 2009
2010 Scrip 100 - David Brennan juggling pharma and PhRMA
09 December 2009
>> More Analysis...
LATEST FEATURES
Anti-obesity drugs: an inventor's perspective
20 November 2009
Xention looks to ion technology to jump start safer treatments
30 October 2009
Face-to-face with Abingworth's Stephen Bunting:we've had time to adapt to tough markets
25 August 2009
>> More Features...
LATEST COMMENT
Commentary: Asia's largest pharma event remarkably upbeat
08 July 2009
Opportunities to sell APIs from regulated markets into India and China - by Kate Kuhrt
01 May 2009
Questions linger over US comparative effectiveness funding
24 February 2009
>> More Comment...
LATEST SCIENCE
Vitamin D and the vasculature: can we teach an old drug new tricks?
13 May 2009
Targeting the angiotensin pathway in idiopathic pulmonary fibrosis
01 December 2008
A 1 adenosine receptor agonists and their potential therapeutic applications
01 December 2008
>> More Science...
REFINE BY
COMPANY/ORGANISATION
PFIZER
GLAXOSMITHKLINE
NOVARTIS
ASTRAZENECA
CONDITION
DIABETES
CANCER
HYPERTENSION
INFARCTION
GEOGRAPHY
JAPAN
GERMANY
CANADA
CHINA
DRUG
SIMVASTATIN
ROFECOXIB
AMLODIPINE
PRASUGREL
